Phase 3
N=2,518
Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
Nosocomial Infections
Bottom Line
View on ClinicalTrials.gov: NCT00549393 ↗Enrolled (actual)
2,518
Serious AEs
0.0%
Results posted
Oct 2015
Primary outcome: Primary: Bacteremia — 3.52; 4.93 events per 1000 at-risk days
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- 2% Chlorhexidine gluconate cloth (Drug)
- Age
- Pediatric, Adult · 0+ yrs
- Sex
- All
- Sponsor
- Johns Hopkins University
- Primary completion
- Dec 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Bacteremia |
3.28; 4.93 | — |
| SECONDARY Central Line Associated-bloodstream Infection (CLABSI) |
1.63; 3.00 | — |
Summary
The investigators propose to conduct a large clinical study to determine if daily bathing with chlorhexidine impregnated cloths will reduce the incidence of healthcare-associated infections in the Pediatric Intensive Care Unit (PICU).
Eligibility Criteria
Inclusion Criteria
- Patients in pediatric intensive care unit
Exclusion Criteria
- Patients with a history of an allergic reaction to chlorhexidine
- Patients less than 2 months of age
- Patients with severe skin disease or burn
- Patients with an indwelling epidural catheter or lumbar drain
Data sourced from ClinicalTrials.gov (NCT00549393). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.